Overview: A Third of New Cancer Drugs Improve Survival Recent discussions at a conference on medicines in Ireland highlighted a striking paradox: while new cancer drugs hold promise, only about a third demonstrably extend overall survival for patients. The head of the National Centre for Pharmacoeconomics warned that many cancer therapies—even those approved—do not translate…